Cenntro Inc. Income Taxes Disclosure
| (1) |
Income taxes
|
|
December 31,
2025
|
December 31,
2024
|
|||||||
|
Current tax (benefit) expense
|
$
|
(2,965 |
)
|
$
|
12,327 |
|||
|
Deferred tax benefit
|
(49,955 |
)
|
(47,851 |
)
|
||||
|
Total tax benefit
|
(52,920 |
)
|
(35,524 |
)
|
||||
|
Less: tax expense of discontinued operation
|
- |
- |
||||||
|
Tax benefit of continuing operation
|
$
|
(52,920 |
)
|
$
|
(35,524 |
)
|
||
|
For the Years Ended
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
PRC
|
$
|
(12,000,684 |
)
|
$
|
(16,182,770 |
)
|
||
|
US
|
(26,402,024 |
)
|
(11,440,101 |
)
|
||||
|
Europe
|
(6,604,383 |
)
|
(14,244,854 |
)
|
||||
|
Australia
|
(27,499,020 |
)
|
(1,406,267 |
)
|
||||
|
Others
|
(568,739 |
)
|
(1,670,149 |
)
|
||||
|
Total losses before income taxes
|
(73,074,850 |
)
|
(44,944,141 |
)
|
||||
|
Less: losses before income taxes for discontinued operations
|
(4,135,717 |
)
|
(10,795,692 |
) |
||||
|
Losses before income taxes for continuing operations
|
$
|
(68,939,133 |
)
|
$
|
(34,148,449 |
)
|
||
|
|
For the Years Ended
December 31,
|
|||||||
|
|
2025
|
2024
|
||||||
|
PRC
|
$
|
- |
$
|
- |
||||
|
US
|
- |
- |
||||||
|
Europe
|
- |
- |
||||||
|
Australia
|
- |
- |
||||||
|
Others
|
- |
- |
||||||
|
Total
|
$
|
- |
$
|
- |
||||
|
For the Years Ended December 31,
|
||||||||||||||||
|
2025
|
2024
|
|||||||||||||||
|
Amount
|
Percentage
|
Amount
|
Percentage
|
|||||||||||||
|
Loss before provision for income tax
|
$
|
(73,074,850 |
)
|
$
|
(44,944,141 |
)
|
||||||||||
|
PRC statutory income tax rate
|
25 |
%
|
25 |
%
|
||||||||||||
|
Income tax expense at the PRC statutory rate
|
(18,268,712 |
)
|
25.0 |
%
|
(11,236,035 |
)
|
25.0 |
%
|
||||||||
|
Effect of preferential tax rate
|
549,898 |
(0.8 |
)%
|
121,460 |
(0.3 |
)%
|
||||||||||
|
Effect of international tax rates
|
1,067,905 |
(1.5 |
)%
|
999,558 |
(2.2 |
)%
|
||||||||||
|
Effect of non-deductible expenses
|
715,517 |
(1.0 |
)%
|
34,568 |
(0.1 |
)%
|
||||||||||
|
Effect of research and development deduction
|
(158,580 |
)
|
0.2 |
%
|
(316,368 |
)
|
0.7 |
%
|
||||||||
|
Fair value change of warrant liability
|
(87,688 |
)
|
0.1 |
%
|
1,035 |
0.0 |
%
|
|||||||||
|
Impairment loss of goodwill
|
- |
0.0 |
%
|
55,874 |
(0.1 |
)%
|
||||||||||
|
Effect of valuation allowance
|
16,128,740 |
(21.9 |
)%
|
10,304,384 |
(22.9 |
)%
|
||||||||||
|
Total income tax benefit
|
$
|
(52,920 |
)
|
0.1 |
%
|
$
|
(35,524 |
)
|
0.1 |
%
|
||||||
| (2) |
Deferred taxes liabilities, net
|
|
December
31,
2025
|
December
31,
2024
|
|||||||
|
Deferred income tax assets:
|
||||||||
|
Impairment loss
|
$
|
5,653,911 |
$
|
4,701,765 |
||||
|
Change in fair value of financial instrument
|
3,680,165 |
1,183,965 |
||||||
|
Capitalization of research and experimental costs
|
850,838 |
- |
||||||
|
Amortization of research and experimental expenses in United States
|
- |
1,073,895 |
||||||
|
Net operating loss carry forwards
|
55,282,430 |
43,534,620 |
||||||
|
Lease liabilities
|
84,428 |
- |
||||||
|
Accrued expenses
|
(138,794 |
)
|
- |
|||||
|
Total deferred income tax assets
|
65,412,978 |
50,494,245 |
||||||
|
Valuation allowance
|
(65,412,978 |
)
|
(50,494,245 |
)
|
||||
|
Deferred income tax assets, net
|
$
|
- |
$
|
- |
||||
|
|
||||||||
|
Deferred tax liabilities:
|
||||||||
|
Assets valuation increase from acquisition
|
(142,312 |
)
|
(171,558 |
)
|
||||
|
Total deferred tax liabilities
|
(142,312 |
)
|
(171,558 |
)
|
||||
|
|
||||||||
|
Net deferred tax liabilities
|
(142,312 |
)
|
(171,558 |
)
|
||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Apr 15, 2026 | Showing above |
| 2024 | Apr 1, 2025 | |
| 2023 | Apr 1, 2024 | |
| 2022 | Jun 30, 2023 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.